CD40LG and myeloid sarcoma: Furthermore, the presence of higher levels of pro-inflammatory factors, such as leptin, sCD40L, MCP-1, IL-6 and sTNF-R [7] in RRMS sera and the specific link with metabolic alterations in the immune system of MS patients suggests MS can be considered a chronic metabolic disorder [37].